Registry for transcatheter valve treatments in heart valve diseases
The Prospective LEUVEN Transcatheter Valve Therapy Registry
This study looks at how safe and effective new heart valve treatments are for people with heart valve diseases to help improve their care and quality of life.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 5000 (estimated) |
| Sex | All |
| Sponsor | Universitaire Ziekenhuizen KU Leuven Academic / other |
| Locations | 1 site (Leuven) |
| Trial ID | NCT03674788 on ClinicalTrials.gov |
What this trial studies
This registry assesses the feasibility, safety, and outcomes of transcatheter valve interventions for patients with heart valve diseases. It aims to describe the patient populations selected for these treatments, procedural aspects, and clinical outcomes following the interventions. The study will also monitor hemodynamic outcomes and quality of life parameters, providing valuable data to tailor treatment indications in this evolving field of interventional cardiology. The design is prospective and non-interventional, focusing on real-world patient experiences.
Who should consider this trial
Good fit: Ideal candidates include all patients selected for percutaneous treatment of a valve disorder.
Not a fit: Patients not selected for percutaneous treatment of a valve disorder may not benefit from this registry.
Why it matters
Potential benefit: If successful, this registry could enhance the understanding of transcatheter valve interventions, leading to improved patient outcomes and tailored treatment strategies.
How similar studies have performed: Other studies have shown success with similar observational approaches in assessing transcatheter valve therapies, indicating a promising avenue for ongoing research.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * All patients selected for percutaneous treatment of a valve disorder potentially qualify for the present registry Exclusion Criteria: * All patients selected for percutaneous treatment of a valve disorder potentially qualify for the present registry. There are no formal exclusion criteria.
Where this trial is running
Leuven
- Department of Cardiology, University Hospital Gasthuisberg — Leuven, Belgium (Recruiting)
Study contacts
- Study coordinator: Christophe Dubois, MD, PhD
- Email: christophe.dubois@uzleuven.be
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.